Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (481-490 of 753) with videos related to

Pageof 76
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study GroupB A Gusterson, R D Gelber, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2006
Henoch-Schönlein purpura (HSP) during treatment with anastrozoleM Conti-Beltraminelli, O Pagani, G Ballerini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2006
Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgeryA Cardillo, C De Cicco, G Paganelli, et al.
Breast Cancer Research and Treatment|August 6, 2013
Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal womenEdoardo Botteri, Elisabetta Munzone, Nicole Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situG Curigliano, D Disalvatore, A Esposito, et al.
Breast Cancer Research and Treatment|February 22, 2012
Why do women accept to undergo a nipple sparing mastectomy or to reconstruct the nipple areola complex when nipple sparing mastectomy is not possible?F Didier, P Arnaboldi, S Gandini, et al.
European Journal of Cancer (Oxford, England : 1990)|September 15, 2007
HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17Rosalba Torrisi, Nicole Rotmensz, Vincenzo Bagnardi, et al.
British Journal of Cancer|January 8, 2009
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanomaA Rocca, S Minucci, G Tosti, et al.
Breast (Edinburgh, Scotland)|March 17, 2015
Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabineGiuseppe Curigliano, Vincenzo Bagnardi, Francesco Bertolini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimenM Colleoni, G Martinelli, F Beretta, et al.
Pageof 76

Showing results (481-490 of 753) with videos related to

Sort By:
Pageof 76
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study GroupB A Gusterson, R D Gelber, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2006
Henoch-Schönlein purpura (HSP) during treatment with anastrozoleM Conti-Beltraminelli, O Pagani, G Ballerini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2006
Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgeryA Cardillo, C De Cicco, G Paganelli, et al.
Breast Cancer Research and Treatment|August 6, 2013
Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal womenEdoardo Botteri, Elisabetta Munzone, Nicole Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situG Curigliano, D Disalvatore, A Esposito, et al.
Breast Cancer Research and Treatment|February 22, 2012
Why do women accept to undergo a nipple sparing mastectomy or to reconstruct the nipple areola complex when nipple sparing mastectomy is not possible?F Didier, P Arnaboldi, S Gandini, et al.
European Journal of Cancer (Oxford, England : 1990)|September 15, 2007
HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17Rosalba Torrisi, Nicole Rotmensz, Vincenzo Bagnardi, et al.
British Journal of Cancer|January 8, 2009
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanomaA Rocca, S Minucci, G Tosti, et al.
Breast (Edinburgh, Scotland)|March 17, 2015
Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabineGiuseppe Curigliano, Vincenzo Bagnardi, Francesco Bertolini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimenM Colleoni, G Martinelli, F Beretta, et al.
Pageof 76